These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 6398312

  • 1. Immunomodulation with thymopentin in humans.
    Bolla K, Duchateau J, Delespesse G, Servais G.
    Int J Clin Pharmacol Res; 1984; 4(6):431-8. PubMed ID: 6398312
    [Abstract] [Full Text] [Related]

  • 2. Modulation of immune response in aged humans through different administration modes of thymopentin.
    Duchateau J, Servais G, Vreyens R, Delespesse G, Bolla K.
    Surv Immunol Res; 1985; 4 Suppl 1():94-101. PubMed ID: 3898299
    [Abstract] [Full Text] [Related]

  • 3. First observations on high-dosed and long-term thymopentin treatment in active rheumatoid arthritis.
    Molin L, Schmid F, Bolla K.
    Int J Clin Pharmacol Res; 1984; 4(6):445-9. PubMed ID: 6398313
    [Abstract] [Full Text] [Related]

  • 4. Thymopentin as adjuvant in non-responders or hyporesponders to hepatitis B vaccination.
    Záruba K, Rastorfer M, Grob PJ, Joller-Jemelka H, Bolla K.
    Lancet; 1983 Nov 26; 2(8361):1245. PubMed ID: 6139582
    [No Abstract] [Full Text] [Related]

  • 5. Thymopentin as adjuvant to hepatitis B vaccination. Results from three double-blind studies.
    Grob PJ, Binswanger U, Blumberg A, Gloor HJ, Hany A, Herwig W, Iselin H, Zàruba K, Bolla K.
    Surv Immunol Res; 1985 Nov 26; 4 Suppl 1():107-15. PubMed ID: 3898281
    [Abstract] [Full Text] [Related]

  • 6. Immunomodulation with thymopentin: in vitro studies.
    Duchateau J, Bolla K.
    Med Oncol Tumor Pharmacother; 1989 Nov 26; 6(1):19-23. PubMed ID: 2657246
    [Abstract] [Full Text] [Related]

  • 7. The effect of thymopentin treatment on the relapse rate in frequently relapsing herpes simplex virus infections.
    Haneke E, Bolla K, Degreef H, Djawari D, Demaubeuge J, Molin L, Panconesi E, Schöpf E, Stengel R, Stingl G.
    Int J Clin Pharmacol Res; 1984 Nov 26; 4(6):439-43. PubMed ID: 6085327
    [Abstract] [Full Text] [Related]

  • 8. Effects of a synthetic extract (thymopentin) on the immune system of lepromatous leprosy patients.
    Munno I, Pellegrino NM, Fumo G, Barbieri G, Polimeno G, de Filippis V, Jirillo E.
    Cytobios; 1987 Nov 26; 52(210-211):167-73. PubMed ID: 3123147
    [Abstract] [Full Text] [Related]

  • 9. Interim results on the clinical effects of i.v. administered thymopentin in active rheumatoid arthritis.
    Malaise M, Franchimont P, Hauwaert C, Danneskiold-Samsoe B, Gross D, Gerber H, Gerschpacher H, Bolla K.
    Int J Clin Pharmacol Res; 1984 Nov 26; 4(6):451-7. PubMed ID: 6398314
    [Abstract] [Full Text] [Related]

  • 10. Preliminary results on clinical and immunological effects of thymopentin in AIDS.
    Clumeck N, van de Perre P, Mascart-Lemone F, Cran S, Bolla K, Duchateau J.
    Int J Clin Pharmacol Res; 1984 Nov 26; 4(6):459-63. PubMed ID: 6398315
    [Abstract] [Full Text] [Related]

  • 11. [Thymopentin in the treatment of recurrent condylomata acuminata].
    Ghetti P, Negosanti M, Andriani GC, Beltrandi E, Maldini M.
    Minerva Ginecol; 1989 Feb 26; 41(2):113-6. PubMed ID: 2664577
    [Abstract] [Full Text] [Related]

  • 12. Influence of thymopentin on antibody response, and monocyte and T cell function in hemodialysis patients who fail to respond to hepatitis B vaccination.
    Dumann H, Meuer SC, Renschin G, Köhler H.
    Nephron; 1990 Feb 26; 55(2):136-40. PubMed ID: 2194133
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Thymopentin (TP-5) potency in vivo is enhanced by slow infusion.
    Audhya T, Goldstein G.
    Int J Pept Protein Res; 1983 Nov 26; 22(5):568-72. PubMed ID: 6360927
    [Abstract] [Full Text] [Related]

  • 15. Thymopentin in the treatment of alopecia areata.
    Orecchia G.
    Dermatologica; 1989 Nov 26; 178(4):231. PubMed ID: 2670621
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.